Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease Reply

被引：0
|
作者：
Yeoh, Aaron [1 ]
Cheung, Ramsey [1 ,2 ]
Ahmed, Aijaz [1 ]
Chitnis, Amit S. [3 ]
Do, Albert [4 ]
Wong, Robert J. [1 ,2 ]
机构：
[1] Stanford, Dept Med, Div Gastroenterol, Palo Alto, CA 94304 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Gastroenterol Sect, Palo Alto, CA USA
[3] Alameda Cty Publ Hlth Dept, Div Communicable Dis Control & Prevent, TB Sect, San Leandro, CA USA
[4] Yale, Dept Med, Div Digest Dis, New Haven, CT USA
来源：
AMERICAN JOURNAL OF MEDICINE | 2024年 / 137卷 / 01期
关键词：
D O I：
10.1016/j.amjmed.2023.08.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E15 / E15
页数：1
相关论文
共 50 条
  • [1] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [2] Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
    Wen, Wen
    Fan, Hua
    Zhang, Shenghui
    Hu, Siqi
    Chen, Chen
    Tang, Jiake
    You, Yao
    Wang, Chunyi
    Li, Jie
    Luo, Lin
    Cheng, Yongran
    Zhou, Mengyun
    Zhao, Xuezhi
    Tan, Tao
    Xu, Fangfang
    Fu, Xinyan
    Chen, Juan
    Dong, Peng
    Zhang, Xingwei
    Wang, Mingwei
    Feng, Yan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (06): : 557 - 568
  • [3] Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?
    Ma, Tianyi
    Yuan, Huawei
    Guo, Zhanfang
    LIVER INTERNATIONAL, 2024, 44 (11) : 3103 - 3104
  • [4] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [5] Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
    Wen, Wen
    Li, Hong
    Wang, Chunyi
    Chen, Chen
    Tang, Jiake
    Zhou, Mengyun
    Hong, Xuwei
    Cheng, Yongran
    Wu, Qi
    Zhang, Xingwei
    Feng, Zhanhui
    Wang, Mingwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    Cardiovascular Diabetology, 21
  • [7] Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
    Jeong, Seogsong
    Oh, Yun Hwan
    Choi, Seulggie
    Chang, Jooyoung
    Kim, Sung Min
    Son, Joung Sik
    Lee, Gyeongsil
    Kim, Won
    Park, Sang Min
    GUT AND LIVER, 2021, : 589 - 598
  • [8] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [9] Predictors of Atherosclerotic Cardiovascular Disease Events in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease
    Kawanaka, Miwa
    Nishino, Ken
    Kawada, Mayuko
    Ishii, Katsunori
    Tanikawa, Tomohiro
    Urata, Noriiyo
    Suehiro, Mitsuhiko
    Haruma, Ken
    Kawamoto, Hirofumi
    INTERNAL MEDICINE, 2024,
  • [10] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
12345